Fabienne Steens

Fabienne Steens joined the EUROBIO SCIENTIFIC group in 2022 following its acquisition of her company, Biomedical Diagnostics (BMD). She leads a team of 10 people from a site located in Antwerp where BMD offers a range of specialized tests and instruments through exclusive distribution contracts, and markets the group's specific products.

‍

‍

Fabienne Steens has more than 30 years of experience in in-vitro diagnostics and the pharmaceutical sector. After graduating with a Master 2 in Chemistry - Biochemistry and Commerce, she began her career by occupying various commercial and marketing positions within BMD Benelux. Wishing to broaden her experience, she then joined the pharmaceutical industry where she was responsible for several marketing and commercial functions allowing her to explore the different facets of the pharmaceutical market both at the hospital level, particularly in oncology, and at the extramural level, wholesalers, pharmacies, GP's. Her last position in this industry was Sales and Marketing Director at Teva Pharmaceutical Industries Ltd. Fabienne Steens then returned to the diagnostics sector by becoming CEO and partner of BMD Benelux, which she acquired in 2014.

‍

‍

BMD, founded in 1986, is today a distribution company, specializing in specialized areas of in-vitro diagnostics. Under Fabienne Steens' management, it has become a key player in the field of autoimmunity but has also developed in the field of infectious diseases, genetic disorders and the monitoring of biotherapies. In addition to its offer of in-vitro diagnostic tests, the company markets an extensive range of quality control reagents.

‍